medline.ch Psychiatrie Schizophrenie und Psychosen

	Effect of long-acting antipsychotic treatment on psychiatric hospitalization rate in early psychosis patients: a naturalistic study. Ther Adv Psychopharmacol Sancho-Echeverria R, Aymerich C, Rodríguez-Sánchez JM, Gil P, Pedruzo B, González-Torres MÁ, Fusar-Poli P, Arango C, Catalan A. PMID: 38644940 [PubMed]
	The Gold Standard Diagnosis of Schizophrenia is Counterproductive: Towards Quantitative Research and Diagnostic Algorithmic Rules (RADAR) and their Derived Qualitative Distinct Classes. Curr Top Med Chem Maes M. PMID: 38644707 [PubMed - as supplied by publisher]
	HERV-W upregulation expression in bipolar disorder and schizophrenia: unraveling potential links to systemic immune/inflammation status. Retrovirology Rangel SC, da Silva MD, Natrielli Filho DG, Santos SN, do Amaral JB, Victor JR, Silva KCN, Tuleta ID, França CN, Shio MT, Neves LM, Bachi ALL, da Silva Nali LH. PMID: 38644495 [PubMed - in process]
	Impacts of a Self-directed Social Resources Study Program on Negative Symptoms and Quality of Life in Schizophrenia Outpatients: A Randomized Controlled Trial. Kobe J Med Sci Nishimura Y, Yotsumoto K, Hashimoto T. PMID: 38644296 [PubMed - in process]
	The relationship between the gut microbiota and oxidative stress in the cognitive function of schizophrenia: A pilot study in China. Schizophr Res Li H, Huang Y, Liang L, Li H, Li S, Feng Y, Feng S, Wu K, Wu F. PMID: 38643725 [PubMed - as supplied by publisher]
	Single-arm meta-analysis of drug response in placebo-controlled versus active-controlled antipsychotic drug trials in schizophrenia. Eur Neuropsychopharmacol Dong S, Schneider-Thoma J, Siafis S, Peter N, Leucht S. PMID: 38643697 [PubMed - as supplied by publisher]
	Clinical and neurodevelopmental predictors of psychotic disorders in children and adolescents at clinical high risk for psychosis: the CAPRIS study. Eur Child Adolesc Psychiatry Dolz M, Tor J, Puig O, de la Serna E, Muñoz-Samons D, Pardo M, Alvarez-Subiela X, Rodriguez-Pascual M, Sugranyes G, Ilzarbe D, Baeza I. PMID: 38642116 [PubMed - as supplied by publisher]
	Asparagine reduces the risk of schizophrenia: a bidirectional two-sample mendelian randomization study of aspartate, asparagine and schizophrenia. BMC Psychiatry Liu HH, Gao Y, Xu D, Du XZ, Wei SM, Hu JZ, Xu Y, Sha L. PMID: 38641826 [PubMed - indexed for MEDLINE]
	Development and initial validation of the cannabis-related psychosis risk literacy scale (CPRL): a multinational psychometric study. BMC Psychiatry Fekih-Romdhane F, Alhuwailah A, Shuwiekh HAM, Stambouli M, Hakiri A, Cheour M, Loch AA, Hallit S. PMID: 38641784 [PubMed - indexed for MEDLINE]
	Therapeutic Potential of Gamma Entrainment Using Sensory Stimulation for Cognitive Symptoms Associated with Schizophrenia. Neurosci Biobehav Rev Black T, Jenkins BW, Laprairie RB, Howland JG. PMID: 38641090 [PubMed - as supplied by publisher]
	Schizophrenia polygenic risk scores, clinical variables and genetic pathways as predictors of phenotypic traits of bipolar I disorder. J Affect Disord Grigoroiu-Serbanescu M, van der Veen T, Bigdeli T, Herms S, Diaconu CC, Neagu AI, Bass N, Thygesen J, Forstner AJ, Nöthen MM, McQuillin A. PMID: 38640977 [PubMed - as supplied by publisher]
	Assessing past suicidal behaviour in schizophrenia spectrum disorders using the Columbia-Suicide Severity Rating Scale and the Beck Scale for Suicide Ideation: Analysis across the life-span. Schizophr Res Al-Chalabi N, Nader G, Gerretsen P, Fischer C, Graff A, Borlido C, Remington G, De Luca V. PMID: 38640852 [PubMed - as supplied by publisher]
	The association between alterations in motor and cognitive dimensions of schizophrenia-spectrum disorders: A systematic review. Schizophr Res Moura BM, Madeira L, Bakker PR, van Harten P, Marcelis M. PMID: 38640851 [PubMed - as supplied by publisher]
	M(1)/M(4) receptors as potential therapeutic treatments for schizophrenia: A comprehensive study. Bioorg Med Chem Fu L, Luo Y, Niu L, Lin Y, Chen X, Zhang J, Tang W, Chen Y, Jiao Y. PMID: 38640587 [PubMed - as supplied by publisher]
	Effect of propranolol on pharmacokinetics of clozapine in schizophrenic patients: a meta-analysis. Eur J Clin Pharmacol Yang X, Yan Q, Yang L, Li J, Fan X, Chen J, Wu H, Yang Y, Zhu R, Fang P. PMID: 38639762 [PubMed - as supplied by publisher]
	EEG analysis in patients with schizophrenia based on microstate semantic modeling method. Front Hum Neurosci Li H, Wang C, Ma L, Xu C, Li H. PMID: 38638803 [PubMed]
	Dissecting the shared genetic landscape of anxiety, depression, and schizophrenia. J Transl Med Tao Y, Zhao R, Yang B, Han J, Li Y. PMID: 38637810 [PubMed - indexed for MEDLINE]
	Blended care in psychosis - A systematic review. Schizophr Res Cohen M, Roe D, Savir T, Baumel A. PMID: 38636358 [PubMed - as supplied by publisher]
	Implementation of Cognitive Behavioral Therapy for psychosis via telehealth: An expert consultation and clinical service model. Psychol Serv Gaither ML, Bassett ED, Wilson AL, Marder SR, Bradford DW, Bernard JD, Glynn SM. PMID: 38635219 [PubMed - as supplied by publisher]
	Trace amine-associated receptor 1 (TAAR1) agonists for psychosis: protocol for a living systematic review and meta-analysis of human and non-human studies. Wellcome Open Res Siafis S, McCutcheon R, Chiocchia V, Ostinelli EG, Wright S, Stansfield C, Juma DO, Mantas I, Howes OD, Rutigliano G, Ramage F, Tinsdeall F, Friedrich C, Milligan L, Moreno C, Elliott JH, Thomas J, Macleod MR, Sena ES, Seedat S, Salanti G, Potts J, Cipriani A, Leucht S, GALENOS team. PMID: 38634067 [PubMed]

Artikel 1 - 20 / 62997

Seite 1 von 3150



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung